Loading...
XJPX
9341
Market cap64mUSD
Dec 05, Last price  
573.00JPY
1D
-1.04%
1Q
-15.74%
IPO
-68.24%
Name

Genova Inc

Chart & Performance

D1W1MN
XJPX:9341 chart
P/E
7.14
P/S
1.01
EPS
80.24
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
10.01b
+15.23%
3,768,667,0004,802,057,0006,513,466,0008,683,488,00010,006,101,000
Net income
1.41b
-18.15%
629,350,000686,270,0001,260,112,0001,726,894,0001,413,468,000
CFO
1.19b
-34.43%
1,056,024,000623,774,0001,203,079,0001,822,117,0001,194,851,000
Dividend
Mar 30, 202630 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay machine dedicated to the clinic; and CLINIC BOT, an AI Chatbot System. The company was founded in 2005 and is headquartered in Tokyo, Japan.
IPO date
Dec 23, 2022
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT